The U.S. government said on Wednesday it will consider opportunities to "bring greater transparency" for the Medicare drug ...

The Trump administration’s Centers for Medicare and Medicaid Services (CMS) has signaled that it will be revamping the ...

A short statement from CMS said the agency will consider ways to make Medicare price negotiations, begun under Biden, more ...

The U.S. government said on Wednesday it will aim for "greater transparency" in Medicare drug price negotiations under ...

The second round of Medicare Part D price negotiations will feature two drugs familiar to rheumatologists — Ofev and Otezla — ...

CMS said it is considering ways to bring "greater transparency" to the Medicare drug pricing negotiation program mandated ...

The US government said on Wednesday it will aim for "greater transparency" in Medicare drug price negotiations under ...

As the next round of Medicare drug pricing negotiations get underway, experts predict President Trump may seek to weaken the program.

Through the issuance of Inauguration Day executive orders, the Trump Administration signaled its apparent intent to tackle ...

An early move by the president has raised questions about what direction his second-term policy on drug costs will take.

House Speaker Mike Johnson said he'd be willing to negotiate with Democrats to raise the debt ceiling, something President ...

Several of Donald Trump’s picks for his Cabinet and key roles in his administration are facing confirmation hearings in the Senate today as the president continues to implement executive actions to ...